Research Article
Safety Analysis of Apatinib Combined with Chemotherapy in the Treatment of Advanced Gastric Carcinoma: A Randomised Controlled Trial
Table 3
Comparison of immune function after treatment (‾x ± s).
| Group | n | CD3+ (%) | CD4+ (%) | CD8+ (%) | CD4+/CD8+ |
| SG | 37 | 62.31 ± 5.29 | 42.56 ± 4.19 | 25.71 ± 3.62 | 1.57 ± 0.18 | RG | 37 | 53.62 ± 5.17 | 33.18 ± 3.84 | 31.21 ± 3.41 | 1.14 ± 0.14 | t | | 7.146 | 10.039 | 6.727 | 11.470 | | | <0.001 | <0.001 | <0.001 | <0.001 |
|
|